Prescription Drug List

Select a brand from the list to view the complete long form or short form. To access approved prescribing information for the products listed below, visit http://us.gsk.com/en-us/products/prescription-medicines-and-vaccines/.

Note: AWPs current as of October 07, 2024.

• DOVATO (dolutegravir/lamivudine) Tablets

• Long form

• Short form

• JESDUVROQ (daprodustat) Tablets

• Long form

• Short form

• JULUCA (dolutegravir/rilpivirine) Tablets

• Long form

• Short form

• OJJAARA (momelotinib) Tablets

• Long form

• Short form

• RUKOBIA (fostemsavir) Extended-Release Tablets

• Long form

• Short form

• TIVICAY (dolutegravir) Tablets

• Long form

• Short form

• TRIUMEQ (lamivudine/dolutegravir sodium/abacavir sulfate) Tablets

• Long form

• Short form

• VOCABRIA (cabotegravir) Tablets

• Long form

• Short form

• ZEJULA (niraparib) Tablets

• Long form

• Short form

Dovato, Juluca, Rukobia, Tivicay, Triumeq, and Vocabria trademarks are owned by or licensed to the ViiV Healthcare group of companies. Access approved prescribing information at: https://www.viivhealthcare.com.

Zejula trademark is owned by or licensed to the GSK group of companies. Access approved prescribing information at: https://gskpro.com/en-us/.
VOCABRIA is part of the optional oral lead-in for patients prescribed CABENUVA or APRETUDE and is not commercially available for sale.